Figure 1. Gene Expression Differences in PFC Area 9 for Six Pairs of Schizophrenic and Control Subjects as Revealed by Microarray Analysis
For each gene group, all expressed genes were classified into signal intensity difference intervals (0.1 bins) according to their Cy5/Cy3 signal ratio. Transcripts in a "1" bin had identical Cy5 versus Cy3 signal intensities. Positive values (to the right) on the x axis denote higher Cy5 signal in schizophrenic subjects (S Ͼ C), negative values (to the left) correspond to higher Cy3 signal intensity in the control subjects (C Ͼ S). The y axis reports the percentage of expressed genes across the six subject pairs per bin for each gene group. In all panels, the white bars (all genes) denote distribution of all expressed genes across the six PFC pairwise comparisons (n ϭ 22,408). (A) Hybridization of two aliquots of the same cortical mRNA from one control subject (all genes control). One aliquot of control cortical mRNA was labeled with Cy3, the other with Cy5, and the combined sample was hybridized onto a single UniGEM-V cDNA microarray. At the 99% confidence level (Ն|1.9|), only four of the 4844 expressed genes (0.08%) reported a false positive Cy5 bias, and two genes (0.04%) reported a false positive Cy3 bias. In contrast with this control experiment, 4.8% of all expressed genes in the six combined PFC comparisons showed a differential expression over the 99% confidence level. Of all expressed genes in the six combined PFC comparisons, 95% of the expressed genes reported Cy3/Cy5 signal intensity ratios Յ|1.6|.
(B-H) Distribution of expressed genes for transcripts related to PSYN group (B), glutamate system (C), GABA system (D), glial markers (E), adhesion molecules (F), cytokines (G), and proteases (H).
Note that genes classified in the PSYN group, glutamate system, and GABA system groups exhibit a pronounced decrease (shift to the left) in transcript expression in the schizophrenic subjects. Statistical tests of this leftward shift are noted in Table 1. dence level (Figure 2A ). For each of the six comparisons, between 6 and 26 genes were changed (13.3%-56.9% of expressed PSYN genes). Furthermore, when combined, out of the total of 246 PSYN group observations, 17.9% of genes showed a decrease at the 99% CL (ՅϪ1.9), and 29.3% showed a significant decrease at the 95% CL (ՅϪ1.6) in the schizophrenic subjects across the six pairwise comparisons (Table 1A) . This shift in the distribution of the PSYN genes was present in all subjects, and it was highly significant for both the individual comparisons and at the level of the combined data (p Ͻ 0.0001). This highly skewed distribution of the PSYN gene group was not due to individual variability between subjects, because individual random variability must occur in both directions. At the 99% CL, 2.2% of all genes were underexpressed in the schizophrenic subjects, suggesting that less than one PSYN gene per subject would be decreased due to the to individual variability (41 expressed genes ϫ 0.022 ϭ 1 gene for a single comparison or 246 ϫ 0.022 ϭ 5.5 genes across all six pairs). Furthermore, in a random distribution, at least six PSYN genes would be expected to show increased expression across the six schizophrenic subjects (246 ϫ 0.028). However, this was not the case for the genes in the PSYN group. Over the 99% CL across the six schizophrenic subjects, only one (0.4%) PSYN gene reported an increase, and 44 (17.9%) PSYN transcripts were decreased. In addition, at the 95% CL we observed only 2 (0.8%) increased and 72 (29.3%) decreased PSYN genes across all the schizophrenic subjects.
In addition to the frequency distribution data, central tendency measurements also revealed a 38% decrease (Ϫ1.48-fold) (p Ͻ 0.005) of all expressed genes in the PSYN group compared to the average expression of all genes (Ϫ1.10) (Table 1B) 
PSYN Gene Expression Deficits Are Different
Black arrows denote "1" bin (identical Cy3/Cy5 signal intensity).
between Schizophrenic Subjects
Green arrowheads depict 95% and red arrowheads denote 99%
The hierarchical data analysis revealed an unexpected individual differences across subject pairs can be interand SGYR1). Y axis denotes expression differences between control and schizophrenic subjects measured by percent of Cy5/Cy3 intensity. Red dashed line represents a transcript decrease of 47.5% (99% CL), green dashed line corresponds to 37.5% decrease trend (95% CL), black dashed line denotes equal Cy5/Cy3 signal (0% STAG5, synaptotagmin 5; SGYR1, synaptogyrin 1; ATPase, vacuolar change). Note that the pattern of decrease in PSYN transcripts difproton pump (42 kDa); GAD67, glutamic acid decarboxylase 1 (67 fers across schizophrenic subjects. Abbreviations: NSF, N-ethylmakDa); and AMPA2, glutamate receptor 2 (AMPA2, GLUR2, GLURB, leimide sensitive factor; SYN2, synapsin II; SJAN1, synaptojanin 1; GRIA2). preted as a result of different patterns of decreased by 26%-74% and 17%-79%, respectively, in the six schizophrenic subjects ( Figure 2B ). To verify the mi-PSYN gene expression across the schizophrenic subjects, some of the observed individual pattern changes croarray findings for these genes, and for two others that exhibited modest changes and only in a few subjects also could be due to the pairwise experimental design and the comparison of each schizophrenic subject to a (synaptojanin 1 [SJAN1] and synaptotagmin 5 [STAG5]), we performed in situ hybridization for five of the same different, matched control. Consequently, we tested the later interpretation in a post hoc manner using the in subject pairs used for the microarray experiments. For pair 794c/665s, no sections were available from the situ hybridization data (see below).
Within the PSYN group, the two most consistently same block of tissue used in the microarray experiment. Radiolabeled cRNA probes specific for NSF, SYN2, altered gene products, NSF and SYN2, were decreased The in situ hybridization data from ten PFC pairwise comparisons were quantified using film densitometry. X axis represents ten pairwise comparisons, Y axis reports corrected film optical density measured across all layers for each control and schizophrenic subject. Lines connecting symbols indicate a matched subject pair. Note that NSF (A) and SYN2 (B), both consistently decreased across the initial six microarray comparisons were also significantly decreased across the ten in situ pairwise comparisons. However, as expected, the two occasionally changed genes in the microarray comparisons, STAG5 (C) and SJAN1 (D), showed inconsistent changes that were marginally significant (indicated in boxes) between the control and schizophrenic subjects.
SJAN1
, and STAG5 were used to localize and quantify and STAG5 changes reported by the microarrays would be altered to a lesser degree only in a subset of schizorelative transcript levels. The in situ hybridization experiments confirmed the microarray findings for the schizophrenic subjects. Indeed, from the second set of pairs, for both STAG5 and SJAN1, only one of five compariphrenic subjects ( Figures 2B, 3, and 4) . At the group level, the decreases determined by microarray and in sons exhibited a Ͼ20% decrease ( Figures 3C and 3D ). Across the ten pairs, due to less consistent decreases situ hybridization experiments were highly correlated (r ϭ 0.70; p Ͻ 0.001).
in expression, overall STAG5 and SJAN1 expression levels were only marginally changed (Ϫ16.2%, p ϭ 0.05, Our findings also suggested that the most consistently observed decreases in transcripts across the microarray and Ϫ14.2%, p ϭ 0.04, respectively). To test if the apparently distinct patterns of decrease experiments (e.g., NSF and SYN2) would reproduce by in situ hybridization in a different cohort of schizophrenic of the PSYN group in individual schizophrenic subjects are present for the NSF, SYN2, STAG5, and SJAN1 subjects. To test this prediction, we examined whether NSF and SYN2, the most affected PSYN transcripts in genes, we analyzed the in situ hybridization data post hoc in an unpaired experimental design. The corrected the six original subject pairs, were also altered in a different cohort of five matched pairs of schizophrenic and OD values, obtained for each schizophrenic subject, were compared to the mean OD values for each of the control subjects. Indeed, in these additional comparisons NSF transcript levels were decreased in all five ten control subjects, as well as to the overall average OD values of the ten control subjects ( Figure 5 ). Across schizophrenic subjects, and SYN2 levels were decreased in four of five schizophrenic subjects. Across the ten schizophrenic subjects, at least four different patterns of decreased expression of NSF, SYN2, STAG5, all ten subject pairs, the mean levels of NSF and SYN2 expression were significantly decreased in the schizoand SJAN1 genes emerged, regardless of control subject used for comparison. The patterns of decreased phrenic subjects by 40% (p Ͻ 0.001) and 37% (p Ͻ 0.005), respectively ( Figures 3A and 3B ). In contrast, we expression also were present when single schizophrenic subjects were compared to the pooled, "reference" conpredicted that the occasional and more modest SJAN1 nosis was no longer significant. In addition, for each of the four genes, no differences in gene expression were observed between the schizophrenic subjects with (n ϭ 4) or without (n ϭ 6) a history of substance abuse, or between those with a diagnosis of schizoaffective disorder (n ϭ 3) or "pure" schizophrenia (n ϭ 7).
Decreased PSYN Expression Is Not Induced by Antipsychotic Treatment
Two subjects with schizophrenia were not receiving antipsychotic medications at the time of death (622s and 547s), and both showed decreased expression of the PSYN group. As an additional strategy to address the influence of chronic exposure to antipsychotic medications ( the power of initial data acquisition from high-density cDNA microarrays, function-related data mining, and conventional molecular biology techniques to confirm trol. The variation patterns observed by in situ hybridizafindings for individual genes. Our finding of a deficit in tion for these four genes are highly suggestive that disthe expression of genes encoding functionally defined tinct patterns of PSYN gene decreases seen on the cascades of proteins underscores the utility of microarmicroarrays are characteristic for subjects with schizorays as screening tools for complex changes in gene phrenia.
expression patterns in psychiatric diseases.
Decreased PSYN Gene Expression Is Not a Result of Confounds
Reduced Expression of Genes Related to the Presynaptic Secretory Machinery For each gene examined by in situ hybridization, group differences in OD measurements were examined using The number of PFC neurons appears to be normal in schizophrenia, and thus loss of neurons cannot account analysis of covariance (ANCOVA) with diagnosis as the main effect and sex, age, postmortem interval, brain pH, for our findings (Pakkenberg, 1993). Furthermore, through our statistical analysis, we demonstrate that the reduced and tissue storage time as covariates. These potential confounds did not account for the observed changes expression of PSYN genes is related to the disease process of schizophrenia and not a consequence of its in the schizophrenic subjects, except for STAG5, where at group level, in an unpaired design, the effect of diagtreatment or a confound of subject characteristics. At the 99% CL, 4.5%-54% of the expressed genes in the schizophrenic subjects without marked individual differences. Furthermore, general synapse loss should pro-PSYN group were decreased in each schizophrenic subject, but the specific genes affected differed across subduce comparable decreases across all synaptic machinery transcripts within a single brain comparison. This did jects. Although some of the less consistent and moderate changes cannot be ruled out as contributing to the not occur in any of the microarray pairwise comparisons: some transcripts encoding presynaptic markers were aldifferences in individual expression profiles, the data suggest that, at least in part, our findings are not due ways unchanged (e.g., syntaxin 1), some were occasionally changed (e.g., synaptogyrin 1, SJAN1, STAG5), and to a generic loss of neuropil. Such a loss would be expected to affect gene expression similarly in all others were consistently changed (e.g., NSF, SYN2, and ascertained by a high throughput genomics approach, in which dozens of genes in multiple molecular cascades some of these loci may be involved in the primary pathophysiology of schizophrenia. For example, deletions in are profiled simultaneously, without a constraining hypothesis or a need for robust linkage to a particular the 22q11-12 region, encoding numerous synapserelated genes, have been associated with a prevalence locus. In the present report, we show that the particular altered transcripts in the PSYN cascade, and the extent of schizophrenia that is 25-fold greater than the general population (Murphy et al., 1999) . Furthermore, a linkage to which they change, varies among subjects, but with consistency in a small number of "most affected" genes. study with a logarithm of odds score of 5.0 on chromosome 17q21 (containing, among others, the NSF and This fits with polygenic, non-Mendelian inherited disorders, in which independent studies produce maximal ATPase genes) has been linked (Bird et al., 1997) How might this occur? The extended period of synaptoand function. The ability to narrow the SNP search from genesis and pruning, from just before birth through adothe hundreds of thousands of possibilities is clearly a lescence in the primate cerebral cortex, is perhaps the major advantage for defining disease associations. Usmost susceptible component of development to epigeing the growing human genome and SNP databases, we netic factors that can influence both the molecular adapcan design novel "sequencing," protein and expression tation of PSYN gene expression and subsequent neuarrays to more fully characterize the underlying molecuronal function. Thus, alterations in synaptic efficacy will lar mechanism of schizophrenia. We suggest that across have an impact on the organization and refinement of schizophrenic subjects altered gene expression patcircuits during the experience-expectant and -depenterns will sort into a continuum related to the variations dent phases of synaptic development. neuropil. Though somewhat far-reaching, we suggest in 1997; Porton et al., 1999), but detailed analysis is needed our model that PSYN dysregulation gives rise to a in primate brain. The added feature of adaptive capaci-"catch-22 scenario" for specific neural circuits, in which ties of different neurons leads directly to the hypothesis subclinical synaptic dysfunction during adolescence that some circuits naturally will be more susceptible to and puberty, due in part to defects in PSYN gene expresfunctional disruption than others. This is readily testable sion, leads to maladaptive mechanisms for synaptic stain forward genetic studies in which mutations are crebilization and circuit function. Given our hypothesis that ated conditionally, both spatially and temporally, providneuronal dysfunction is dependent on the expression ing a substrate for analysis of predictable molecular of the altered PSYN susceptibility genes, certain develadaptations and physiological consequences. Few of oping circuits will be affected in a more pronounced these experiments have been performed, but recent refashion than others. A falsifiable experiment would inports provide evidence for complex and not necessarily corporate the use of additional microarray data to define predictable changes in synaptic plasticity and molecular adaptive PSYN gene expression patterns, which will help adaptations. design.
Experimental Procedures Microarrays
The experiments were performed on UniGEM-V high-density cDNA Characteristics of Subjects microarrays (Incyte Pharmaceuticals, Fremont, CA). These cDNA Two groups of subjects, consisting of six and five pairs of schizomicroarrays test human gene expression using genes and ESTs phrenic and control subjects, were used in these studies. Subject from the public domain UniGene database. Each array compares a pairs were completely matched for sex (18 males and 4 females).
sample to a control by Cy3/Cy5 dual fluorescent hybridization. Each Eight subjects were diagnosed with "pure" schizophrenia, while in UniGEM-V array contains over 7000 unique and sequence verified three subjects the diagnosis was schizoaffective disorder. All but cDNA elements mapped to 6794 UniGene Homo sapiens annotated two of the schizophrenic subjects were receiving antipsychotic clusters. The gene names are updated to build 110. medications at the time of death, and five had a history of alcohol abuse or dependence.
The mean (Ϯ SD) difference within pairs was 4.6 Ϯ 3.5 years for If a gene or EST was differentially expressed, the cDNA feature on the array bound more of the labeled probe from one sample than DSM-IIIR diagnoses were made for all 22 subjects using data from the other, producing either a greater Cy3 or Cy5 signal intensity. assembly protein, clathrin-associated adaptor protein (large, ␤-1), dynamin (1 and 2), dynein (axonemal and cytoplasmic), endobrevin, The arrays were scanned at Incyte, the signal intensities were color coded and downloaded into a local database (SQL Server 7.0). Note kinesin (1, 2, 4 heavy chains), neurexin 1, NSF, P/Q ␣-1 Ca channel, rab3a, rabaptin 5, rabphillin 3a, SAP90A, SCAMP 3, SNAP (␣ and that the operators were blind to the specific category to which each sample belonged. Data analysis was performed using GemTools ␥), synaptotagmin (I, IV For in situ hybridization, we designed custom primers for each of Observations in this category suggested comparable expression the sequence-verified clones of interest. These primers were used between the schizophrenic and control sample. In our Cy3/Cy5 conto produce ds cDNA molecules of 750-950 bp using PCR and normal trol experiment ( Figure 1A ) and in Incyte's verification study, Ͼ95% human brain cDNA template. The products of these reactions were of all observations fell into this category. These observations may ligated into a plasmid vector and transformed into competent E. contain real differences between samples that are indistinguishable coli cells. For quantification of the in situ hybridization signal, we used Scion Observations in this category report a real expression difference Image (version 3). The investigators were blind to the sample catebetween the schizophrenic and control sample at the 99% configory. Uncalibrated optical density (OD) values were measured from dence level. In the control experiments, Ͻ0.5% of the observations high resolution scans of X-ray film (X-Omat AR, Kodak) that had fell into this category. been exposed to the processed slides for 2-3 days prior to being developed. The mean relative OD was calculated for each section Gene Groups in five nonoverlapping rectangular regions with a width of ‫005ف‬ m The gene groups related to metabolic pathways, enzymes, and funcand adjusted in length to span cortical layers 2-6. The long axis of tional pathways are part of GemTools' gene hierarchy analysis capaeach rectangular region was positioned in parallel with the orientability. To obtain the list of gene groups, visit http://pittarray.neurobio. tion of cortical cells. The OD of the white matter in the section was pitt.edu/neuron/. In addition, gene groups related to brain-specific subtracted from each of these measurements to give five relative functions were designed using recent review articles. UniGEM-V OD values for each subject. For group comparisons, the mean of microarrays did not contain probes for all known genes related to these five values was used for each subject. a single gene group. Unless it was certain that only one member of a given gene family performed a certain synaptic function, all gene family members represented on the microarrays were included in
Probe Preparation and Array Hybridization

Monkey Experiments
Two pairs of male cynomolgus (Macaca fascicularis) monkeys, the gene groups (e.g., synaptotagmin I, II, IV, V, VII, IX, XI). To maximize the potential of novel discovery, isoforms with an uncermatched for age and weight, were studied. One pair was compared on the cDNA microarrays, and both pairs were analyzed by in situ tain brain expression were also occasionally included in the custom gene groups (e.g., syntaxin family genes). However, as only exhybridization. In each pair, one animal was treated for 10-12 months with the antipsychotic medication haloperidol decanoate at doses pressed genes were included in the analysis, inclusion of family members with absent brain expression did not affect the analysis that produced trough serum levels (4-5 ng/ml), known to be in the therapeutic range for the treatment of schizophrenia. Consistent and interpretation of the data.
The custom-designed gene groups related to brain-specific funcwith our attempt to mimic the clinical model of neuroleptic threshold dosing, all haloperidol-treated animals developed extrapyramidal tions included transcripts for structural proteins, glial markers, neuronal markers, transcription factors, protein kinases, apoptosis symptoms that were effectively controlled with maintenance administration of benztropine mesylate (Akil et al., 1999; Pierri et al., 1999). markers, growth factors, growth factor receptors, cytokines, adhesion molecules, G proteins, cAMP pathway, DNA binding proteins, The brain tissue was processed identically to the human samples. For cross-species hybridizations, Incyte required three times the metalloproteinases, heat shock proteins, presynaptic secretory machinery, GABA system, catecholamine system, glutamate system, amount of mRNA for array hybridization. Based on the detection of expressed genes, the hybridizations were as successful as the huneuropeptides, voltage-gated channels, ligand-gated channels, and Alzheimer disease-related genes. man sample hybridizations. The in situ analysis of monkey tissue was performed on areas 9 in sections matched for rostrocaudal Genes in the PSYN group represented on the arrays (n ϭ 62) were as follows: clathrin (both light and heavy polypeptides), clathrin coat location. 
Statistical Analysis
